113 related articles for article (PubMed ID: 12356799)
1. Pharmacokinetics and ocular penetration of grepafloxacin in albino and pigmented rabbits.
Perez S; Solans C; Bregante MA; Pinilla I; García MA; Honrubia F
J Antimicrob Chemother; 2002 Oct; 50(4):541-5. PubMed ID: 12356799
[TBL] [Abstract][Full Text] [Related]
2. Ocular penetration of grepafloxacin after intravitreal administration in albino and pigmented rabbits.
Solans C; Bregante MA; Garcia MA; Perez S
Chemotherapy; 2004 Jun; 50(3):133-7. PubMed ID: 15282440
[TBL] [Abstract][Full Text] [Related]
3. Grepafloxacin concentration in ocular tissues after intravenous infusion in rabbits with intraocular inflammation.
Pérez-Oliván S; Pinilla I; Bregante MA; Solans C; Ruiz Moreno O; Garcia MA; Honrubia FM
Ophthalmic Res; 2005; 37(6):335-40. PubMed ID: 16158011
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of balofloxacin in the intraocular tissues of pigmented rabbits].
Ooishi M; Miyao M; Abe T; Sasagawa T; Motoyama M; Nakagawa T; Okutomi T
Jpn J Antibiot; 1995 Sep; 48(9):1274-80. PubMed ID: 7474337
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of grepafloxacin.
Efthymiopoulos C
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():35-43. PubMed ID: 9484872
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
[TBL] [Abstract][Full Text] [Related]
7. Effect of food and gastric pH on the bioavailability of grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():18-24. PubMed ID: 9433652
[TBL] [Abstract][Full Text] [Related]
8. Differences between albino and pigmented rabbit eyes in the intraocular pharmacokinetics of sparfloxacin.
Fukuda M; Sasaki K
Drugs; 1995; 49 Suppl 2():314-6. PubMed ID: 8549346
[No Abstract] [Full Text] [Related]
9. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
[TBL] [Abstract][Full Text] [Related]
10. Effect of age and gender on the pharmacokinetics of grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():9-17. PubMed ID: 9433651
[TBL] [Abstract][Full Text] [Related]
11. Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction.
Efthymiopoulos C; Bramer SL; Maroli A; Flaherty JF; Wolfe E; Bass N; Somberg K
Clin Pharmacokinet; 1997; 33 Suppl 1():25-31. PubMed ID: 9433653
[TBL] [Abstract][Full Text] [Related]
12. Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes.
Fukuda M; Sasaki K
Lens Eye Toxic Res; 1989; 6(1-2):339-51. PubMed ID: 2488026
[TBL] [Abstract][Full Text] [Related]
13. Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
Regnier A; Schneider M; Concordet D; Toutain PL
Am J Vet Res; 2008 Mar; 69(3):410-5. PubMed ID: 18312141
[TBL] [Abstract][Full Text] [Related]
14. Theophylline and warfarin interaction studies with grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A; Blum B
Clin Pharmacokinet; 1997; 33 Suppl 1():39-46. PubMed ID: 9433655
[TBL] [Abstract][Full Text] [Related]
15. Physiologically-based pharmacokinetic analysis of grepafloxacin.
Nakajima Y; Hattori K; Shinsei M; Matsunaga N; Iizasa H; Sasabe H; Akiyama H; Miyanmoto G; Nakashima E
Biol Pharm Bull; 2000 Sep; 23(9):1077-83. PubMed ID: 10993208
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.
Liu W; Liu QF; Perkins R; Drusano G; Louie A; Madu A; Mian U; Mayers M; Miller MH
Antimicrob Agents Chemother; 1998 Jun; 42(6):1417-23. PubMed ID: 9624487
[TBL] [Abstract][Full Text] [Related]
17. [The dynamics of melanin-affinitive and non-affinitive antibacterial agents in the iris-ciliary body of rabbit eyes--comparative studies in pigmented and albino rabbits].
Fukuda M; Sasaki K
Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1229-33. PubMed ID: 1332455
[TBL] [Abstract][Full Text] [Related]
18. Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin.
Pfister M; Zhang L; Hammarlund-Udenaes M; Sheiner LB; Gerber CM; Täuber MG; Cottagnoud P
Antimicrob Agents Chemother; 2003 Jan; 47(1):138-43. PubMed ID: 12499181
[TBL] [Abstract][Full Text] [Related]
19. Effect of renal impairment on the pharmacokinetics of grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A; Gambertoglio JG
Clin Pharmacokinet; 1997; 33 Suppl 1():32-8. PubMed ID: 9433654
[TBL] [Abstract][Full Text] [Related]
20. Disposable 1-day Acuvue contact lenses for the delivery of lomefloxacin to rabbits' eyes.
Tian X; Iwatsu M; Kanai A
CLAO J; 2001 Oct; 27(4):212-5. PubMed ID: 11725984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
